Table 2.
Association between anaplastic lymphoma kinase copy number gain and clinicopathological characteristics of hepatocellular carcinoma patients n (%)
| Characteristics | Total cases |
ALK/CNG |
P value | |
| Positive (28 cases) | Negative (185 cases) | |||
| Age (yr) | ||||
| < 49 | 105 | 12 (11.4) | 93 (88.6) | 0.465 |
| ≥ 49 | 108 | 16 (14.8) | 92 (85.2) | |
| Sex | ||||
| Female | 17 | 3 (17.6) | 14 (82.4) | 0.843 |
| Male | 196 | 25 (12.8) | 171 (87.2) | |
| Grade | ||||
| I + II | 116 | 12 (10.3) | 104 (89.7) | 0.186 |
| III + IV | 97 | 16 (16.5) | 81 (83.5) | |
| Stage | ||||
| I + II | 174 | 21 (12.1) | 153 (87.9) | 0.326 |
| III + IV | 39 | 7 (17.9) | 32 (82.1) | |
| Relapse | ||||
| No | 83 | 13 (15.7) | 70 (84.3) | 0.385 |
| Yes | 130 | 15 (11.5) | 115 (88.5) | |
| AFP (ng/mL) | ||||
| < 400 | 125 | 19 (15.2) | 106 (84.8) | 0.290 |
| ≥ 400 | 88 | 9 (10.2) | 79 (89.8) | |
| Child-Pugh- classification | ||||
| A | 195 | 25 (12.8) | 170 (87.2) | 0.922 |
| B + C | 18 | 3 (16.7) | 15 (83.3) | |
| HBV DNA | ||||
| Positive | 113 | 17 (15.0) | 96 (85.0) | 0.383 |
| Negative | 100 | 11 (11.0) | 89 (89.0) | |
| Postoperative platelet count | ||||
| < 100 × 109/L | 35 | 2 (5.7) | 33 (94.3) | 0.250 |
| ≥ 100 × 109/L | 178 | 26 (14.6) | 152 (85.4) | |
ALK/CNG: Anaplastic lymphoma kinase copy number gain; AFP: Alpha fetoprotein; HBV: Hepatitis B virus.